Cargando…
Nasal microbiome disruption and recovery after mupirocin treatment in Staphylococcus aureus carriers and noncarriers
Nasal decolonization procedures against the opportunistic pathogen Staphylococcus aureus rely on topical antimicrobial drug usage, whose impact on the nasal microbiota is poorly understood. We examined this impact in healthy S. aureus carriers and noncarriers. This is a prospective interventional co...
Autores principales: | Baede, Valérie O., Barray, Anaïs, Tavakol, Mehri, Lina, Gérard, Vos, Margreet C., Rasigade, Jean-Philippe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671894/ https://www.ncbi.nlm.nih.gov/pubmed/36396730 http://dx.doi.org/10.1038/s41598-022-21453-4 |
Ejemplares similares
-
Can mupirocin prevent methicillin-resistant Staphylococcus aureus infections?
por: Wertheim, Heiman FL, et al.
Publicado: (2005) -
Reduced Costs for Staphylococcus aureus Carriers Treated Prophylactically with Mupirocin and Chlorhexidine in Cardiothoracic and Orthopaedic Surgery
por: van Rijen, Miranda M. L., et al.
Publicado: (2012) -
Identification of Nasal Gammaproteobacteria with Potent Activity against Staphylococcus aureus: Novel Insights into the “Noncarrier” State
por: Cole, Amy L., et al.
Publicado: (2021) -
Nasal decolonization of Staphylococcus aureus with mupirocin: strengths, weaknesses and future prospects
por: Coates, T., et al.
Publicado: (2009) -
Mupirocin resistant staphylococcus aureus nasal colonization among healthcare workers
por: Wattal, Chand, et al.
Publicado: (2014)